A possible explanation for the suppressive effect of ApoA in CLL is that ApoA-I can decrease the level of IL-6, a major mediator of inflammation, which contributes to the survival of CLL patients. Here, APOA1 is linked to B-cell chronic lymphocytic leukemia.